Cargando…
Development of an imaging system for visualization of Ebola virus glycoprotein throughout the viral lifecycle
Ebola virus (EBOV) causes severe EBOV disease (EVD) in humans and non-human primates. Currently, limited countermeasures are available, and the virus must be studied in biosafety level-4 (BSL-4) laboratories. EBOV glycoprotein (GP) is a single transmembrane protein responsible for entry into host ce...
Autores principales: | Furuyama, Wakako, Sakaguchi, Miako, Yamada, Kento, Nanbo, Asuka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669576/ https://www.ncbi.nlm.nih.gov/pubmed/36406413 http://dx.doi.org/10.3389/fmicb.2022.1026644 |
Ejemplares similares
-
RNA Virus-Encoded miRNAs: Current Insights and Future Challenges
por: Nanbo, Asuka, et al.
Publicado: (2021) -
A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection
por: Furuyama, Wakako, et al.
Publicado: (2020) -
The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway
por: Furuyama, Wakako, et al.
Publicado: (2021) -
Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
por: Bhatia, Bharti, et al.
Publicado: (2021) -
Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection
por: Furuyama, Wakako, et al.
Publicado: (2020)